If you require further searching capabilities for announcements please email: data@nzx.com
Market release 29 March 2017 NOTICE PURSUANT TO LISTING RULE 7.12.1 For the purposes of Rule 7.12.1 of the NZX Main Board Listing Rules, AFT Pharmaceuticals Limited (NZX: AFT; ASX:AFP) advises that the following Securities have been issued: a) Class of Security Unlisted redeemable preference shares in AFT Pharmaceuticals Limited ("Redeemable Preference Shares") ISIN: N/A b) Number issued: 3,330,000 Redeemable Preference Shares c) Issue price: $2.74 per Redeemable Preference Share d) Payment in cash: Yes e) Amount paid up: Fully paid f) Principal terms of the Securities See AFT Pharmaceuticals Limited's market announcement of 17 March 2017 for a summary of the principal terms of the Redeemable Preference Shares g) Percentage of the total of Class of Securities issued: 100% h) Reason for issue: See AFT Pharmaceuticals Limited's market announcement of 17 March 2017 for the reasons for the issue of the Redeemable Preference Shares i) Specific authority for issue: Board resolution j) Terms or details of issue: See AFT Pharmaceuticals Limited's market announcement of 17 March 2017 for a summary of the details of the issue of Redeemable Preference Shares k) Total number of Securities of the Class in existence after issue: 3,330,000 Redeemable Preference Shares l) Treasury stock N/A m) Date of issue: 24 March 2017 [End of release] For more information: Malcolm Tubby CFO, AFT Pharmaceuticals Ltd Phone: +64 9 488 0232 End CA:00299043 For:AFT Type:GENERAL Time:2017-03-30 09:08:51